• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

AZ delivers 1.8m doses ahead of mass rollout

firstwordpharmaJune 07, 2021

Tag: AstraZeneca , COVID-19 , Vaccine

Thailand's publish health ministry said AstraZeneca delivered 1.8 million locally produced COVID-19 vaccine doses, the first of 6 million scheduled for delivery this month, reported the Bangkok Post.

AZ delivers 1.8m doses ahead of mass rollout

AstraZeneca said it started receiving deliveries from its authorised producer Siam Bioscience last week.

James Teague, AstraZeneca's country president, said the delivery was significant and marked the start of a sustainable supply of the vaccine in Thailand.

The company would be able to supply the vaccine as scheduled in Thailand, and begin shipments to other Asean countries in July, he said.

Previous:South Korea's IP laws key to expanding COVID-19 vaccine partnership: US senators

Next:Dr Reddy’s recalls 2,980 bottles of Atorvastatin Calcium tablets in US

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

AZ delivers 1.8m doses ahead of mass rollout | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

IPV(Inactivated Poliovirus Vaccine)

IPV(Inactivated Poliovirus Vaccine)
Varicella Vaccine,Live (Pre-filled syringe)

Varicella Vaccine,Live (Pre-filled syringe)
Influenza Vaccine(Split Virion),Inactivated

Influenza Vaccine(Split Virion),Inactivated
Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral
Pet Vaccine Series

Pet Vaccine Series
Automatic GMP Washing and Drying System Meet Requirement of Pharmaceutical and Vaccine Production

Automatic GMP Washing and Drying System Meet Requirement of Pharmaceutical and Vaccine Production
Human Vaccine

Human Vaccine
OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral

OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral
DTaP-Hib combined Vaccine

DTaP-Hib combined Vaccine
Freeze-Dried Live Attenuated Varicella Vaccine

Freeze-Dried Live Attenuated Varicella Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service